-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PAC-1 in Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PAC-1 in Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PAC-1 in Lymphoma Drug Details: PAC-1 (also known as VO-100) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PAC-1 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PAC-1 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PAC-1 in Solid Tumor Drug Details: PAC-1 (also known as VO-100)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PAC-1 in Neuroendocrine Tumors
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PAC-1 in Neuroendocrine Tumors report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PAC-1 in Neuroendocrine Tumors Drug Details: PAC-1 (also known as VO-100)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PAC-1 in Pancreatic Endocrine Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PAC-1 in Pancreatic Endocrine Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PAC-1 in Pancreatic Endocrine Tumor Drug Details: PAC-1 (also known...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IFx-Hu20 in Cutaneous Squamous Cell Carcinoma (cSCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IFx-Hu20 in Cutaneous Squamous Cell Carcinoma (cSCC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IFx-Hu20 in Cutaneous Squamous Cell Carcinoma (cSCC) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Elenagen in Kidney Cancer (Renal Cell Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Elenagen in Kidney Cancer (Renal Cell Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Elenagen in Kidney Cancer (Renal Cell Cancer) Drug...
-
Product Insights
NewQuarterly Dried & Instant Noodles pricing trends in the United States
Empower your strategies with our Quarterly Dried & Instant Noodles pricing trends in the United States report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate,...
-
Sector Analysis
NewRomania Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2029
Romania Defense Market Report Overview In 2024, Romania's defense budget is worth $8.6 billion. The country’s defense budget will grow at a CAGR of more than 2% during 2025-2029. Defense industry development is one of the prominent factors leading to the growth of the market. Romania Defense Market Outlook, 2024-2029 ($ Billion) Buy the Full Report for More Insights into the Romania Defense Market Forecast Download a Free Report Sample The Romania defense market research report provides the market size...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PAC-1 in Metastatic Uveal Melanoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PAC-1 in Metastatic Uveal Melanoma Drug Details: PAC-1 (also known as VO-100) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IFx-Hu20 in Nonmelanomatous Skin Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IFx-Hu20 in Nonmelanomatous Skin Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IFx-Hu20 in Nonmelanomatous Skin Cancer Drug Details: IFx-Hu20 is under development...